Identification of an allosteric binding site on the transcription factor p53 using a phage-displayed peptide library

Oncogene

Volumn 16, Issue 15, 1998, Pages 1993-1999

  Ravera, M W ^a   Carcamo J ^a   Brissette, R ^a   Alam Moghe A ^a   Dedova, O ^a   Cheng, W ^a   Hsiao, K C ^a   Klebanov, D ^a   Shen, H ^a   Tang, P ^a   Blume, A ^a   Mandecki, W ^a  

^a DGI BioTechnologies   (United States)

Author keywords

Antibody; Epitope mapping; PAb1620; Sequence; Structure function

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53; TRANSCRIPTION FACTOR;

ANTIBODY COMBINING SITE; ARTICLE; BINDING SITE; EPITOPE MAPPING; GENE LIBRARY; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DNA BINDING;

EID: 7144257184     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201717     Document Type: Article

References (26)

1. Appel JR, Pinilla C, Niman H and Houghten R. (1990). J. Immunol., 144, 976-983.
2. Chen YCJ, Delbrook K, Dealwis C, Mimms L, Mushawar IK and Mandecki W. (1996). Proc. Natl. Acad. Sci. USA. 93, 1997-2001.
3. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
4. Ellgaard L, Holtet TL, Moestrup SK, Etzerodt M and Thogersen HC. (1995). J. Immunol. Methods, 180, 53-61.
5. Grihalde ND, Chen YC, Golden A, Gubbins E and Mandecki W. (1995). Gene, 166, 187-195.
6. Hainaut P, Soussi T, Shomer B, Hollstein M, Greenblatt M, Hovig E, Harris CC and Montesano R. (1997). Nucleic Acids Res., 25, 151-157.
7. Halazonetis TD, Davis LJ and Kendil AN. (1993). EMBO J., 12, 1021-1028.
8. Halazonetis TD and Kandil AN. (1993). EMBO J., 12, 5057-5064.
9. Hall AR and Milner J, (1995). Oncogene, 10, 561-567.
10. Hopp TP, Prickett KS, Prive V, Libby RT, March CJ, Cerretti P, Urdal DL and Conlon PJ. (1988). Biotechnology, 6, 1205-1210.
11. Houghten RA. (1985). Proc. Natl. Acad. Sci. USA, 82, 5131-5135.
12. Kay BK, Adey NB, He YS, Manfredi JP, Mataragnon AH and Fowlkes DM, (1993). Gene, 128, 59-65.
13. Lane DP, Stephen CW, Midgley CA, Sparks A, Hupp TR, Daniels DA, Greaves R, Reid A, Vojtesek B and Picksley SM. (1996). Oncogene, 12, 2461-2466.
14. Levine AJ. (1997). Cell, 88, 323-331.
15. Mandecki W, Brissette R, Carcamo J, Cheng W, Dedova O, Hsiao KC, Moghe A, Ravera M, Shen H, Tang P and Blume A. (1997). Display Technologies - Novel Targets and Strategies. P Guttry (ed). International Business Communications, Inc: Southborough, MA. pp. 231-254.
16. Milner J, Cook A and Sheldon M. (1987). Oncogene, 1, 453 - 455.
17. Milner J and Medcalf EA. (1990). J. Mol. Biol., 216, 481 - 484.
18. Niewolik D, Vojtesek B and Kovarik J. (1995). Oncogene. 10, 881-890.
19. Pinilla C, Appel JR and Houghten RA. (1993). Gene, 128, 71-76.
20. Renschler MF, Bhatt RR, Dower WJ and Levy R. (1994). Proc. Natl. Acad. Sci. USA, 91, 3623-3627.
21. Romano JW, Ehrhart JC, Duthu A, Kim CM. Apella E and May P. (1989). Oncogene, 4, 1483 - 1488.
22. Scott JK and Smith GP. (1990). Science. 249, 386-390.
23. Stephen CW and Lane DP. (1992). J. Mol. Biol., 225, 577-583.
24. Stephen CW, Helminen P and Lane DP. (1995). J. Mol. Biol., 248, 58-78.
25. Wade-Evans A and Jenkins JR. (1985). EMBO J., 4, 699-706.
26. Yewdell JW, Gannon JV and Lane DP. (1986). J. Virol., 59, 444-452.